eltrombopag
Not Tagged
['bet']
poster 1127 #ash22 29% of patients treated with tpo-ras could discriminate treatment with 2 year median followup. the next question is what are the predictors of this? 
Peds hem/onc enthusiast with interest in med ed (and now a PD @ UCSF), QI & safety, hemostasis/thrombosis. Former Saipan pediatrician. Tweets are my own